logo-loader

Advanced Oncotherapy maps out plans for growth following £30mln deal with Yantai CIPU

Published: 08:18 13 Dec 2017 GMT

Nicolas Serandour, chief executive of Advanced Oncotherapy PLC (LON:AVO), visited the Proactive Investors studio to add some extra detail to their recent announcement that they've secured £37.4mln of fresh funding - £30mln of this coming from a new Chinese investor.

The injection will bankroll the continuing technical development of the firm’s first LIGHT system and its installation at the Harley Street Proton Therapy Centre.

FTSE rises ahead of Easter weekend, JD Sport gains on upbeat outlook -...

The FTSE 100 gained on the final morning of this shortened Easter trading week. Festive cheer was limited though, as Thames Water confirmed shareholders would not provide it with a £500 million rescue package, prompting speculation over the London supplier’s future. On a more positive...

1 hour, 16 minutes ago